Advertisement

Instant Oncology: The BC2001/BCON Meta-Analysis

      Conflicts of Interest

      The author declares no conflict of interest.

      References

        • James N.D.
        • Hussain S.A.
        • Hall E.
        • Jenkins P.
        • Tremlett J.
        • Rawlings C.
        • et al.
        Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.
        N Engl J Med. 2012; 366: 1477-1488
        • Huddart R.A.
        • Hall E.
        • Hussain S.A.
        • Jenkins P.
        • Rawlings C.
        • Tremlett J.
        • et al.
        Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).
        Int J Radiat Oncol Biol Phys. 2013; 87: 261-269
        • Hoskin P.J.
        • Rojas A.M.
        • Bentzen S.M.
        • Saunders M.I.
        Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.
        J Clin Oncol. 2010; 28: 4912-4918
        • Song Y.P.
        • Mistry H.
        • Irlam J.
        • Valentine H.
        • Yang L.
        • Lane B.
        • et al.
        Long term outcomes of radical radiotherapy with hypoxia modification with biomarker discovery for stratification: ten year update of the BCON (Bladder CarbOgen Nicotinamide) phase III randomised trial (ISRCTN45938399).
        Int J Radiat Oncol Biol Phys. 2021; (ahead of print)https://doi.org/10.1016/j.ijrobp.2021.03.001
        • Choudhury A.
        • Porta N.
        • Hall E.
        • Song Y.P.
        • Owen R.
        • MacKay R.
        • et al.
        Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials.
        Lancet Oncol. 2021; 22: 246-255
        • Advanced Bladder Cancer (ABC) Meta-analysis Collaboration
        Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.
        Eur Urol. 2005; 48: 202-205
        • van Leeuwen C.M.
        • Oei A.L.
        • Crezee J.
        • Bel A.
        • Franken N.A.P.
        • Stalpers L.J.A.
        • et al.
        The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
        Radiat Oncol. 2018; 13: 96